CVE-2026-52866Active Exploitation

LOW

Exploitation ongoing with high activity in latest observed window (1 mentions)

Immediate actions

  • Prioritize remediation for affected systems immediately
  • Assume compromise if assets are exposed
  • Track advisory updates for patch or workaround availability

Recommended action window: Immediate (within 24h)

3.5/ 10 priority

Priority

LOW

Exploitation

ACTIVE

PoC

NONE

Patch

NONE

Momentum

NONE

Threat summary

  • Active exploitation appears in 1 classified signals
  • 1 mentions across 1 observed day

What's happening

  • Active exploitation reported across 1 signal
  • Technical details provided in 1 signal
  • 1 total mentions across 1 day

Deep dive

Activity timeline1 mentions / 1d
00111Mentions · 2026-06-19: 1Active Exploitation · 2026-06-19: 1Technical Details · 2026-06-19: 106-19
Signal classification1 categories
Active Exploitation
1100.0%
Referenced assets1 URL
Full discourse1 post
  • Aviatrix Threat Research Center@aviatrixtrc
    Active Exploitation

    TRC analysis reveals attackers exploiting CVE-2026-50034 and CVE-2026-52866 in Apollo Pharmacy's BLE glucose monitors to intercept unencrypted health data and monopolize device connections. This demonstrates how proximity-based attacks can compromise both data confidentiality and device availability in medical IoT. #MedicalIoT #BLE 🔗 Full breakdown: https://aviatrix.ai/threat-research-center/apollo-pharmacy-blood-glucose-monitoring-system-apg-01-bt-vulnerabilities-2026

    Post summary

    TRC analysis confirms attackers are exploiting CVE-2026-50034 and CVE-2026-52866 in Apollo Pharmacy’s BLE glucose monitors, allowing them to intercept patient data and monopolize device connections, illustrating the risks of proximity‑based attacks on medical IoT devices.

    0000036
    1.9K followersView on X

Explore more